Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)
Clinical trial NCT02899169 · UNKNOWN
Trial details
- NCT number
- NCT02899169
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2022-09-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.